Results 4,501-4,520 of 11,979 for speaker:Billy Kelleher

Joint Oireachtas Committee on Health and Children: Cost of Prescription Drugs: Discussion (Resumed) (12 Mar 2015)

Billy Kelleher: I seek three clarifications.

Joint Oireachtas Committee on Health and Children: Cost of Prescription Drugs: Discussion (Resumed) (12 Mar 2015)

Billy Kelleher: I shall be brief. Can a prescribing audit be carried out in pharmacies? Audits would allow us to see trends, for example, of local GPs prescribing expensive drugs. The audit could be done in a general practice. Is an audit carried out on a random basis? Is scientific data pulled from the reimbursement figures? I wish to mention parallel trading but shall not go into too much detail....

Joint Oireachtas Committee on Health and Children: Cost of Prescription Drugs: Discussion (Resumed) (12 Mar 2015)

Billy Kelleher: It does occur, obviously.

Joint Oireachtas Committee on Health and Children: Cost of Prescription Drugs: Discussion (Resumed) (12 Mar 2015)

Billy Kelleher: If one is shifting from cheap markets through parallel trading to dear markets, surely that is going to help the pharmaceutical companies eventually.

Joint Oireachtas Committee on Health and Children: Cost of Prescription Drugs: Discussion (Resumed) (12 Mar 2015)

Billy Kelleher: The next time in, they are saying that they do not have that.

Joint Oireachtas Committee on Health and Children: Cost of Prescription Drugs: Discussion (Resumed) (12 Mar 2015)

Billy Kelleher: All right.

Joint Oireachtas Committee on Health and Children: Cost of Prescription Drugs: Discussion (Resumed) (12 Mar 2015)

Billy Kelleher: I asked about where products get launched.

Joint Oireachtas Committee on Health and Children: Cost of Prescription Drugs: Discussion (Resumed) (12 Mar 2015)

Billy Kelleher: They could be launched in Germany, too, I would imagine.

Written Answers — Department of Health: HSE Legal Cases (11 Mar 2015)

Billy Kelleher: 100. To ask the Minister for Health the amount that has been paid in compensation over the past four years by the Health Service Executive either through the courts or by settlement; and if he will make a statement on the matter. [10651/15]

Written Answers — Department of Health: Nursing Homes Support Scheme Data (11 Mar 2015)

Billy Kelleher: 115. To ask the Minister for Health the number of persons currently awaiting placement under the fair deal scheme; the average waiting time; and if he will make a statement on the matter. [10750/15]

Misuse of Drugs (Amendment) Bill 2015: Second Stage (10 Mar 2015)

Billy Kelleher: We will support the Bill. I thank the Minister and his officials for the information provided to us in recent hours in preparation for the debate. The most reassuring aspect of the Minister's speech is the fact that the Department was aware of the situation and had prepared for this potential finding of the Court of Appeal following the challenge that was taken. While it is emergency...

Joint Oireachtas Committee on Health and Children: General Scheme of Public Health (Alcohol) Bill 2015: Royal College of Physicians of Ireland (10 Mar 2015)

Billy Kelleher: I welcome the witnesses. Professor Murray outlined in stark detail the difficulties that we as a nation have with drink and our unhealthy relationship with alcohol. For a long time, there has been a tacit acceptance that we have a little problem with drink which we are incapable of dealing with or facing up to as a mature society. While the issue has been swept under the carpet for a long...

Written Answers — Department of Social Protection: Fuel Allowance Eligibility (10 Mar 2015)

Billy Kelleher: 160. To ask the Minister for Social Protection the working age benefits or allowances that do not permit recipients to apply for the fuel allowance. [9910/15]

Written Answers — Department of Public Expenditure and Reform: Public Sector Staff Recruitment (10 Mar 2015)

Billy Kelleher: 235. To ask the Minister for Public Expenditure and Reform if the Public Appointments Commission has the discretion to permit someone to proceed to the next stage of the recruitment process in the following circumstances (details supplied). [10039/15]

Written Answers — Department of Public Expenditure and Reform: Care of the Elderly Provision (10 Mar 2015)

Billy Kelleher: 239. To ask the Minister for Public Expenditure and Reform if he will reconsider the transfer of the senior alert scheme to Pobal, as there have been a number of issues raised (details supplied); and if he will make a statement on the matter. [10357/15]

Written Answers — Department of Health: Departmental Communications (10 Mar 2015)

Billy Kelleher: 401. To ask the Minister for Health with regard to his recent speech to the Institute of Directors, his views on whether it is appropriate that a Government Department, funded by the taxpayer, should circulate such a politically partisan speech; his further views on whether the press office of the political party of which he is a member is the appropriate forum by which to distribute such...

Written Answers — Department of Health: Ambulance Service Provision (10 Mar 2015)

Billy Kelleher: 407. To ask the Minister for Health if his Department has received any communications in the past month from the Department of the Environment, Community and Local Government indicating that it is opposed to the proposed changes with regard to the Dublin Fire Brigade ambulance service being merged with the National Ambulance Service. [10157/15]

Protection of Life During Pregnancy (Amendment) (Fatal Foetal Abnormalities) Bill 2015: First Stage (5 Mar 2015)

Billy Kelleher: They are gagging Parliament over there.

Protection of Life During Pregnancy (Amendment) (Fatal Foetal Abnormalities) Bill 2015: First Stage (5 Mar 2015)

Billy Kelleher: The Government opposed a Bill three weeks ago.

Joint Oireachtas Committee on Health and Children: Cost of Prescription Drugs: Discussion (5 Mar 2015)

Billy Kelleher: I welcome the witnesses. This is an issue that causes much concern. Legislation has been brought through the Houses of the Oireachtas in recent years to try to address the cost of medicines to the taxpayer. Clearly, our obligation is to ensure we get the balance right so that we have a vibrant market and we get value for the taxpayer. We have a strong pharmaceutical base in this country,...